Increasing Prevalence of Osteoporosis Across the Globe to Drive the Market

Thu, 18 April 2019 5:42

Osteoporosis is a disease mainly occurred after post-menopausal ladies and elderly males due to excessive bone desorption or diminished new bone formation or both. In osteoporosis condition absolute bone mass is less than normal is increased risk of fracture in the absence of significant trauma.

According to the International Osteoporosis Foundation, around 54 million Americans, half of all adults aged above 50 suffered from osteoporosis.  Increasing prevalence of hip fracture across the globe due to calcium and vitamin D deficiency, rising obese population, increasing prevalence of smoking.  Growing number of incidence accident due to over speeding is supporting the growth of the market. Apart from this, increasing geriatric population suffering from osteoporosis is supporting the growth of the market. Additionally, no one treatment can completely cure osteoporosis completely is restrains of the growth of the market.

Segmental Insight

The global anti-osteoporosis therapy and fracture healing market is segmented by route of administration and drug type.

 Bisphosphonates is expected leading segment owing to recommended as a first line treatments for post-menopausal osteoporosis.

Regional Insight

Geographically, the global anti-osteoporosis therapy and fracture healing market is segmented into North America, Europe, Asia pacific, and LAMEA.

North America is expected to hold the major market share during forecast period 2019–2026. This is attributed to high prevalence of hips fracture in the U.S. Huge presence of baby bombers population suffering from osteoporosis and low & back pain are the factors likely to drive the market in the region. For instance, according to the Population Reference Bureau, in 2014, approximately 46 million American people aged above 65 which are estimated to grow to 98 million by 2060.

Europe is expected to witness significant growth of anti-osteoporosis therapy and fracture healing market in the forecast period 2019-2026. This is attributed to increasing prevalence of smoking in U.K. owing to the decreased absorption of calcium from food which leads to osteoporosis.

Asia pacific is expected to be the fastest growing market for anti-osteoporosis therapy and fracture healing.  Increasing incidences of accidents in India due to over speeding, drunken driving, and red light jumping is influence demand for fracture healing market.

Latin America and the Middle East & Africa (LAMEA) is expected to experience steady growth in the market owing to the poor development of healthcare infrastructure and facilities.

Key Players

Some of the major players in anti-osteoporosis therapy and fracture healing market are , Actavis plc, F.Hoffmann La Roche Ltd., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Merck and Company Inc., Amgen Inc., GlaxoSmithKline plc, and Pfizer, Inc., Novartis International AG.